REG - Craneware plc - Vesting of Long Term Incentive Plan Awards

CranewareAnnouncement

23/09/2022 09:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220923:nRSW4475Aa&default-theme=true

RNS Number : 4475A  Craneware plc  23 September 2022

Craneware plc

("Craneware" or the "Company")

 

Vesting of Long Term Incentive Plan Awards

 

23 September 2022 - The Board of Craneware plc (AIM: CRW.L), the market leader
in Value Cycle solutions for the US healthcare market, announces that on 21
September 2022, under the terms of the Craneware plc Long Term Incentive Plan
(2016) ("LTIP"), conditional awards of ordinary shares of 1p each in the
Company ("Shares") which were granted to three Directors of the Company,
vested to the extent that certain performance conditions were satisfied.

 

 Director               Date of grant of conditional share award  Net amount of Shares received from conditional share awards vested on 21  Percentage of issued share capital of the Company
                                                                  September 2022
 Keith Neilson (CEO)    5 September 2018                          1,901
                        4 September 2019                          4,217
                                                                  ________
                                                                  Total 6,118                                                               0.017%
                                                                  ________

 Craig Preston (CFO)    5 September 2018                          1,408
                        4 September 2019                          3,135
                                                                  ________
                                                                  Total 4,543                                                               0.013%
                                                                  ________

 Isabel Urquhart (CPO)  4 September 2019                          1,723                                                                     0.005%

 

The net amount of Shares received by each of the Directors from the vested
LTIP awards was after payment of the associated tax liabilities. No
consideration was payable by each of the Directors to receive the Shares from
these LTIP awards.

 

 

Following this transaction, Keith Neilson holds 3,440,304 Shares which is
9.68% of the issued share capital of the Company, Craig Preston holds 93,872
Shares which is 0.26% of the issued share capital of the Company and Isabel
Urquhart holds 8,300 Shares which is 0.02% of the issued share capital of the
Company.

 

PDMR notification: Keith Neilson

 

1.   Details of the Restricted Person / person closely associated with him
or her

a)
Name
Keith Neilson

 

2.   Reason for the notification

a) Position /
status
CEO

b) Initial notification / Amendment               Initial
notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
Craneware plc

b)
LEI
213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
         Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification
code
          ISIN GB00B2425G68

 

c) Nature of the
transaction
Vesting of conditional share awards under the     Craneware plc Long Term
Incentive Plan (2016)

 

d) Price(s) and volume(s)
                       Volume(s) released from vested
awards 6,118,

 Price(s) £0

 

e) Aggregated information:

            i. Aggregated volume
                      Aggregate volume released 6,118

            ii.
Price
                      Price(s) £0

 

f) Date of the transaction
          2022-09-21

 

g) Place of the transaction
         Outside a trading venue

 

 

PDMR notification: Craig Preston

 

1.   Details of the Restricted Person / person closely associated with him
or her

a)
Name
Craig Preston

 

2.   Reason for the notification

a) Position /
status
CFO

b) Initial notification / Amendment               Initial
notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
Craneware plc

b)
LEI
213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification
code                                  ISIN
GB00B2425G68

 

c) Nature of the transaction
Vesting of conditional share awards under the Craneware plc

 
Long Term Incentive Plan (2016)

 

d) Price(s) and
volume(s)                            Volume(s)
released from vested awards 4,543, Price(s) £0

 

e) Aggregated information:

                             i. Aggregated
volume                Aggregate volume released 4,543

                             ii.
Price
Price(s) £0

 

f) Date of the transaction
2022-09-21

 

g) Place of the transaction
Outside a trading venue

 

PDMR notification: Isabel Urquhart

 

1.   Details of the Restricted Person / person closely associated with him
or her

a)
Name
Isabel Urquhart

 

2.   Reason for the notification

a) Position /
status
Chief People Officer

b) Initial notification / Amendment               Initial
notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
            Craneware plc

b)
LEI
213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification
code                                  ISIN
GB00B2425G68

 

c) Nature of the transaction
Vesting of conditional share award under the Craneware plc

 
                        Long Term Incentive Plan (2016)

 

d) Price(s) and
volume(s)                            Volume(s)
released from vested award 1,723, Price(s) £0

 

e) Aggregated information:

                             i. Aggregated
volume                Aggregate volume released 1,723

                             ii.
Price
Price(s) £0

 

f) Date of the transaction
2022-09-21

 

g) Place of the transaction
Outside a trading venue

 

 

For further information, please contact:

 

Craneware
plc
+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial
PR)
+44 (0)20 3405 0205

Caroline Forde, Hilary Buchanan, Joe
Pederzolli
craneware@almapr.co.uk

Peel Hunt (NOMAD and Joint Broker)
 
+44 (0)20 7418 8900

Dan Webster, Andrew Clark

Investec Bank PLC (Joint
Broker)
+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Sebastian Lawrence

Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff

 

About Craneware

We at The Craneware Group of companies, including our latest additions Sentry
Data Systems and Agilum Healthcare Intelligence, passionately believe we can
impact healthcare profoundly by delivering the insights healthcare
organisations need to also transform the business of healthcare. Our shared
vision is to be the operational and financial partner for US healthcare
providers.

 

Our combined suite of applications and industry-leading team of experts help
our customers contextualise operational, financial, and clinical data,
providing insights that clearly demonstrate what great looks like. These value
cycle insights deliver revenue integrity and 340B compliance, as well as
margin and operational intelligence- something no other single partner can
provide.

 

Together, approximately 40% of registered U.S. hospitals are now our
customers, including more than 12,000 US hospitals, health systems and
affiliated retail pharmacies and clinics. Our customers are operating with a
financial impact of nearly half a trillion dollars. We have data sets from
customers covering more than 150 million unique patients encounters.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCVXLBLLKLBBBL